Predicting how residents will perform in the field
Dr. Brigitte Smith received a $1.1 million precision education grant from AMA to build a platform that will help vascular surgery training programs analyze residents’ and recent graduates' performance data.
A comprehensive approach to dementia
No cure exists — yet — for Alzheimer’s disease, the brain disorder that slowly destroys memory and thinking skills, along with the ability to complete daily tasks. But dozens of researchers at the University of Wisconsin–Madison, many of them within the UW School of Medicine and Public Health, are working on ways to prevent, slow and cure the disease.
Overriding a genetic mutation to restore sight
A University of Wisconsin–Madison research team has shown that an engineered molecule can override a genetic error that causes a rare but devastating form of inherited childhood blindness, restoring the missing protein and recovering visual function in patient-derived cells and in a mouse model of the disease.
UW–Madison researchers identify therapeutic target for dangerous fungal infections
A multidisciplinary team of researchers at UW–Madison has identified a promising new therapeutic candidate against Candida auris, an emerging fungal pathogen able to resist multiple antifungal drugs and spread rapidly through hospitals and care facilities.
New research tracks tick distribution and rising disease risk across Wisconsin
While most people dread finding a tick stuck to their clothing or skin, Johnny Uelmen is literally beating the bushes for them.
UW spinoff company launches clinical trial for metastatic cancer treatment
The first patient in a clinical trial led by Archeus Technologies has received a dose of an investigational therapy to treat metastatic cancer, developed by the clinical-stage company which has ties to the University of Wisconsin–Madison, UW Health’s Isthmus Project and the Wisconsin Alumni Research Foundation.
Research agreement signed with Accuray to improve personalized cancer care
A new 10‑year strategic collaboration between the University of Wisconsin School of Medicine and Public Health and Accuray Incorporated will support clinical research, education and training, and development of adaptive therapies that help empower medical care teams to continually raise the standard in cancer care.
Collaborative research effort reveals biomarkers for Huntington’s disease
Two UW professors collaborated to analyze a large dataset from PREDICT-HD, one of the largest studies of early Huntington’s disease ever conducted.
Scientists discover molecular mechanism that could boost calorie burning
GLP-1 drugs have transformed weight loss by suppressing appetite. The other half of the equation — helping the body burn more energy — has received less attention.
Clinical trial tests new cell therapy to manage kidney transplant rejection
A first-of-its-kind clinical trial at the Program for Advanced Cell Therapy will examine a new method to manage kidney rejection following transplant.
Eight researchers transforming colorectal cancer care
March is National Colorectal Cancer Awareness Month, established to raise awareness for a disease that is largely preventable. Colorectal cancer is now the leading cause of cancer death in adults under 50 and the only major cancer where mortality is rising in younger adults, according to a 2026 report from the American Cancer Society.
How AI is advancing medical research
Able to absorb, examine and analyze staggering amounts of data, artificial intelligence (AI) helps medical researchers identify disease patterns and predict patient outcomes.